Purchases and Sales Made in Q2 2022 in Biomarin Pharmaceutical Inc (BMRN)
This table provides information about the institutional ownership of Biomarin Pharmaceutical Inc (BMRN) during Q2 2022. The information is specifically focused on institutions that hold shares of BIOMARIN PHARMACEUTICAL INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 09, 2022
Q2 2022
|
Nan Fung Trinity (Hk) LTD
Central, Hong Kong, K3 |
SELL
|
- |
-63.4K- 22.61% |
$4.53M - $5.51M
|
217K
$14.5M
|
|
|
Aug 16, 2022
Q2 2022
|
International Biotechnology Trust PLC
London, X0 |
SELL
|
- |
-73.1K- 91.71% |
$5.22M - $6.34M
|
6.6K
$440K
|
|
|
Aug 16, 2022
Q2 2022
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-75.1K- 83.67% |
$5.37M - $6.52M
|
14.7K
$977K
|
|
|
Aug 08, 2022
Q2 2022
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-75.4K- 65.2% |
$5.39M - $6.55M
|
40.3K
$2.68M
|
|
|
Aug 15, 2022
Q2 2022
|
Palo Alto Investors LP
Palo Alto, CA |
SELL
|
- |
-78.2K- 3.66% |
$5.59M - $6.8M
|
2.06M
$137M
|
|
|
Aug 12, 2022
Q2 2022
|
Rhenman & Partners Asset Management Ab
Stockholm, V7 |
SELL
|
- |
-80K- 36.36% |
$5.72M - $6.95M
|
140K
$9.33M
|
|
|
Aug 12, 2022
Q2 2022
|
Credit Suisse Ag
Zurich, V8 |
SELL
|
- |
-82.1K- 15.87% |
$5.87M - $7.13M
|
435K
$29M
|
|
|
May 14, 2024
Q2 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-85.1K- 9.37% |
$6.08M - $7.39M
|
823K
$54.8M
|
|
|
Aug 15, 2022
Q2 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-87.4K- 90.97% |
$6.25M - $7.59M
|
8.68K
$578K
|
|
|
Aug 15, 2022
Q2 2022
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-100K- 6.78% |
$7.15M - $8.69M
|
1.38M
$91.6M
|
|
|
Aug 11, 2022
Q2 2022
|
Primecap Management CO
Pasadena, CA |
SELL
|
- |
-101K- 0.57% |
$7.22M - $8.77M
|
17.7M
$1.18B
|
|
|
Aug 01, 2022
Q2 2022
|
Calamos Advisors LLC
|
SELL
|
- |
-110KClosed |
$7.86M - $9.55M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-148K- 89.9% |
$10.6M - $12.8M
|
16.6K
$1.11M
|
|
|
Aug 15, 2022
Q2 2022
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-159K- 3.64% |
$11.3M - $13.8M
|
4.2M
$280M
|
|
|
Aug 15, 2022
Q2 2022
|
Melqart Asset Management (Uk) LTD
London, X0 |
SELL
|
- |
-163K- 49.48% |
$11.7M - $14.2M
|
167K
$11.1M
|
|
|
Aug 10, 2022
Q2 2022
|
Ubs Group Ag
|
SELL
|
- |
-168K- 5.87% |
$12M - $14.6M
|
2.69M
$179M
|
|
|
Aug 15, 2022
Q2 2022
|
Pura Vida Investments, LLC
New York, NY |
SELL
|
- |
-175KClosed |
$12.5M - $15.2M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-211KClosed |
$15.1M - $18.4M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-219KClosed |
$15.6M - $19M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-219K- 59.69% |
$15.7M - $19M
|
148K
$9.85M
|
|
|
Jul 27, 2022
Q2 2022
|
Sea Town Holdings Pte. Ltd.
|
SELL
|
- |
-226K- 64.89% |
$16.1M - $19.6M
|
122K
$8.14M
|
|
|
Aug 15, 2022
Q2 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-226K- 68.85% |
$16.2M - $19.6M
|
102K
$6.82M
|
|
|
Aug 03, 2022
Q2 2022
|
Handelsbanken Fonder Ab
|
SELL
|
- |
-232K- 76.77% |
$16.6M - $20.2M
|
70.3K
$4.68M
|
|
|
Aug 15, 2022
Q2 2022
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-269KClosed |
$19.2M - $23.3M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-275K- 55.0% |
$19.7M - $23.9M
|
225K
$15M
|
|
|
Aug 12, 2022
Q2 2022
|
Natixis
Paris, I0 |
SELL
|
- |
-619K- 73.47% |
$44.3M - $53.8M
|
224K
$14.9M
|
|
|
Jul 12, 2022
Q2 2022
|
Manning & Napier Group, LLC
|
SELL
|
- |
-759K- 44.5% |
$54.3M - $65.9M
|
946K
$63.1M
|
|
|
Aug 15, 2022
Q2 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-937K- 44.84% |
$67M - $81.4M
|
1.15M
$76.8M
|
|
|
Aug 11, 2022
Q2 2022
|
Clearbridge Investments, LLC
New York, NY |
SELL
|
- |
-984K- 46.66% |
$70.4M - $85.5M
|
1.13M
$75M
|
|
|
Aug 15, 2022
Q2 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-1.06M- 66.98% |
$76.1M - $92.5M
|
525K
$35M
|
|
|
Aug 15, 2022
Q2 2022
|
Capital Research Global Investors
Los Angeles, CA |
SELL
|
- |
-4.45M- 47.43% |
$318M - $387M
|
4.94M
$329M
|